New Dengue Vaccine Suspended in Brazil After Severe Adverse Event Reports
Brazil’s Ministry of Health and the National Health Surveillance Agency (ANVISA) suspended a mass vaccination campaign using a new dengue vaccine developed by a Brazilian biomedical research center after severe adverse events, including deaths, were associated with certain batches of the vaccine. Authorities have opened an investigation into the incidents while continuing to assess the […]